Haiquan Lu



Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Haiquan Lu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma

Lu, H., Lu, Y., Xie, Y., Qiu, S., Li, X. & Fan, Z., Jan 1 2019, In : JCI Insight. 4, 19, e131106.

Research output: Contribution to journalArticle

  • Reciprocal regulation of DUSP9 and DUSP16 expression by HIF1 controls ERK and p38 MAP kinase activity and mediates chemotherapy-induced breast cancer stem cell enrichment

    Lu, H., Tran, L., Park, Y., Chen, I., Lan, J., Xie, Y. & Semenza, G. L., Aug 1 2018, In : Cancer Research. 78, 15, p. 4191-4202 12 p.

    Research output: Contribution to journalArticle

  • Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment

    Lu, H., Chen, I., Shimoda, L., Park, Y., Zhang, C., Tran, L., Zhang, H. & Semenza, G. L., Feb 21 2017, In : Cell Reports. 18, 8, p. 1946-1957 12 p.

    Research output: Contribution to journalArticle

  • ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis

    Lu, H., Li, X., Lu, Y., Qiu, S. & Fan, Z., Oct 10 2016, In : Cancer Letters. 381, 1, p. 23-30 8 p.

    Research output: Contribution to journalArticle